Trial intelligence / Profile preview

Lidocaine injections in vastus intermedius and rectus femoris for post-stroke stiff knee gait

NL-OMON20633Recruiting

Sponsor
Roessingh Research & Development
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of lidocaine in stroke, sponsored by Roessingh Research & Development. Primary endpoint: Knee flexion during gait. Started Jul 2019; status: recruiting.

02

Drugs

lidocaine
03

Conditions

stroke

Beyond the preview

Go deeper on NL-OMON20633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call